Ligand Pharmaceuticals
LGND
#3426
Rank
ยฃ3.07 B
Marketcap
ยฃ154.01
Share price
0.73%
Change (1 day)
97.30%
Change (1 year)

P/S ratio for Ligand Pharmaceuticals (LGND)

P/S ratio as of April 2026 (TTM): 15.3

According to Ligand Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.02. At the end of 2025 the company had a P/S ratio of 14.0.

P/S ratio history for Ligand Pharmaceuticals from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
202514.013.06%
202412.330.17%
20239.4845.3%
20226.53-29.93%
20219.318.57%
20208.58-41.18%
201914.630.16%
201811.2-45.29%
201720.55.1%
201619.5-35.21%
201530.186.35%
201416.1-26.59%
201322.056.36%
201214.180.84%
20117.775.16%
20107.3913.73%
20096.50-31.74%
20089.52-73.03%
200735.3142.56%
200614.6192.86%
20054.97-7.18%
20045.36-29.68%
20037.6291.88%
20023.97-71.82%
200114.1

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.10-60.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
2.46-83.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
12.8-16.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
4.99-67.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
0.7631-95.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
4.54-70.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.44-83.99%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2.55-83.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
8.22-46.14%๐Ÿ‡บ๐Ÿ‡ธ USA